# Acrivon Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 23, 2026

- Company: [Acrivon Therapeutics, Inc.](/companies/acrv.md) (CIK 1781174)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:29 ET
- Period: not reported
- Accession: 0001346824-26-000116
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1781174/000134682426000116/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781174/000134682426000116/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781174/000134682426000116/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000116. Last ingested by Listed: Nov 11, 2026, 02:42 ET. No prices; not investment advice.
